Independent fund research. Built on SEC filings.

How we research funds

ETF overlap

JDOC vs SHSSX overlap: 55% of top holdings shared

Bottom line

How much do JDOC and SHSSX overlap?

55% of their top holdings overlap by weight. 14 securities appear in both funds' top 25, making up 52.9% of JDOC's assets and 52.0% of SHSSX's. They share a meaningful core but differ in the rest of the portfolio.

SHSSX holds far more positions (155 vs 61), so it is broader beyond the top names.

Updated Nov 22, 2026

Overlap at a glance

JDOCSHSSX
Weight overlap (top 25)55%
Shared holdings14
Weight in shared holdings52.9%52.0%
Total positions61155
Expense ratio0.65%0.86%
Holdings as ofJul 31, 2026May 29, 2026

Source: SEC Form N-PORT (periods Jul 31, 2026 / May 29, 2026)

Holdings JDOC and SHSSX have in common

Holding% of JDOC% of SHSSXOverlap
AbbVie, Inc.7.85%3.94%3.94%
Eli Lilly & Co.7.76%12.29%7.76%
UnitedHealth Group, Inc.5.85%6.10%5.85%
Merck & Co., Inc.4.82%4.94%4.82%
Johnson & Johnson4.82%8.77%4.82%
AstraZeneca plc3.76%1.21%1.21%
Thermo Fisher Scientific, Inc.3.73%3.02%3.02%
Abbott Laboratories3.11%1.97%1.97%
Stryker Corp.2.23%1.15%1.15%
Danaher Corp.2.16%2.00%2.00%
Intuitive Surgical, Inc.1.93%1.95%1.93%
Edwards Lifesciences Corp.1.73%2.51%1.73%
Regeneron Pharmaceuticals, Inc.1.60%0.91%0.91%
Biogen, Inc.1.56%1.21%1.21%

Source: SEC Form N-PORT (periods Jul 31, 2026 / May 29, 2026)

Free weekly newsletter

The Fund Letter

Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.

Free. Unsubscribe anytime. We never sell your email.

What each fund holds that the other doesn't

Top-25 holdings that appear in only one of the two funds' top 25.

Only in JDOC

  1. Bristol-Myers Squibb Co. — 3.57%
  2. CVS Health Corp. — 2.83%
  3. Roche Holding AG — 2.82%
  4. Novo Nordisk A/S — 2.61%
  5. GSK plc — 2.47%
  6. Cencora, Inc. — 2.07%
  7. Argenx SE — 2.06%
  8. IQVIA Holdings, Inc. — 1.71%
  9. Teva Pharmaceutical Industries Ltd. — 1.60%
  10. Novartis AG — 1.60%
  11. Cardinal Health, Inc. — 1.51%

Only in SHSSX

  1. Gilead Sciences Inc — 4.19%
  2. Amgen Inc — 3.37%
  3. Vertex Pharmaceuticals Inc — 2.74%
  4. Pfizer Inc — 2.61%
  5. Teva Pharmaceutical Industries Ltd — 1.87%
  6. Boston Scientific Corp — 1.59%
  7. Elevance Health Inc — 1.56%
  8. Argenx Se — 1.26%
  9. Blackrock Funds III — 1.01%
  10. Revolution Medicines Inc — 0.96%
  11. Humana Inc — 0.92%

Asset mix

Asset typeJDOCSHSSX
Stocks99.2%99.8%
Cash & short-term funds—1.4%

Source: SEC Form N-PORT (periods Jul 31, 2026 / May 29, 2026)

Country mix

CountryJDOCSHSSX
US75.2%93.9%
GB6.2%1.4%
CH4.4%1.4%
DK4.0%—
JP2.5%0.2%
NL2.4%1.3%
IL1.6%1.9%
DE1.9%0.1%

Source: SEC Form N-PORT (periods Jul 31, 2026 / May 29, 2026)

Check another pair

FAQ

How much do JDOC and SHSSX overlap?
About 55% by weight. 14 securities appear in both funds' top 25 holdings; they make up 52.9% of JDOC's assets and 52.0% of SHSSX's. They share a meaningful core but differ in the rest of the portfolio.
What stocks do JDOC and SHSSX have in common?
The largest shared holdings are Eli Lilly & Co., UnitedHealth Group, Inc., Merck & Co., Inc., Johnson & Johnson, AbbVie, Inc..
Should I own both JDOC and SHSSX?
They overlap in part. Owning both concentrates you in the shared names; check that the combined weight in those stocks is what you intend.
Which holds more stocks, JDOC or SHSSX?
SHSSX is broader, with 155 positions versus 61 for JDOC. Overlap here is measured on each fund's top 25 holdings, which carry most of the weight.

Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.